Holen Sie sich die Stockscreener-App
0.1964
9.62%
-0.0209
Handel nachbörslich:
.20
0.0036
+1.83%
Schlusskurs vom Vortag:
$0.2173
Offen:
$0.22
24-Stunden-Volumen:
2.51M
Relative Volume:
0.17
Marktkapitalisierung:
$6.63M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-18.35M
KGV:
-0.1693
EPS:
-1.16
Netto-Cashflow:
$-19.20M
1W Leistung:
-11.21%
1M Leistung:
-27.61%
6M Leistung:
-59.06%
1J Leistung:
-83.36%
1-Tages-Spanne:
$0.1945
$0.22
1-Wochen-Bereich:
$0.1945
$0.2359
52-Wochen-Spanne:
$0.1945
$2.08
Theriva Biologics Inc Stock (TOVX) Company Profile
Firmenname
Theriva Biologics Inc
Sektor
Branche
Telefon
301 417 4364
Adresse
9605 Medical Center Drive, Suite 270, Rockville
Vergleichen Sie TOVX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TOVX
Theriva Biologics Inc
|
0.1964 | 7.33M | 0 | -18.35M | -19.20M | -1.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Theriva Biologics Inc Aktie (TOVX) Neueste Nachrichten
Why Theriva Biologics Inc. stock is a strong buy call2025 Analyst Calls & AI Driven Stock Reports - Newser
Can Theriva Biologics Inc. (SFY0) stock test all time highs2025 Market Overview & Verified Swing Trading Watchlists - Newser
Why Theriva Biologics Inc. stock gets analyst attention2025 Institutional Moves & Weekly Top Performers Watchlists - Newser
How Theriva Biologics Inc. (SFY0) stock reacts to Fed tightening2025 Market Overview & Smart Investment Allocation Insights - Newser
Will Theriva Biologics Inc. stock outperform foreign stocksTake Profit & Daily Profit Focused Stock Screening - Newser
Will Theriva Biologics Inc. stock maintain strong growthQuarterly Earnings Summary & Fast Gain Stock Trading Tips - Newser
Can Theriva Biologics Inc. stock reach $200 price targetJuly 2025 Fed Impact & AI Optimized Trading Strategy Guides - Newser
Will Theriva Biologics Inc. stock beat value stocksMarket Movers & Growth Focused Stock Pick Reports - Newser
Theriva Biologics (NYSE: TOVX) files resale for 16,184,560 warrant shares - Stock Titan
Can Theriva Biologics Inc. stock deliver consistent EPS growthPortfolio Return Report & Low Drawdown Trading Techniques - Newser
Will Theriva Biologics Inc. stock top growth indexesTrade Exit Summary & Safe Entry Zone Identification - Newser
Will Theriva Biologics Inc. stock outperform benchmarks2025 Market Overview & Weekly High Return Opportunities - Newser
How Theriva Biologics Inc. stock reacts to monetary easingJuly 2025 Market Mood & AI Forecasted Stock Moves - Newser
Risks Report: Will Theriva Biologics Inc SFY0 stock draw ESG focused fundsWeekly Trade Recap & Accurate Entry and Exit Point Alerts - BỘ NỘI VỤ
Healthy Upside Potential: Theriva Biologics Inc (TOVX) - Setenews
Why Theriva Biologics Inc. stock appeals to dividend investors2025 Market WrapUp & Reliable Volume Spike Alerts - moha.gov.vn
Is Theriva Biologics Inc. stock supported by strong fundamentals2025 Volume Leaders & Weekly High Return Stock Forecasts - moha.gov.vn
EPS Watch: Why Theriva Biologics Inc. stock appeals to dividend investorsJuly 2025 News Drivers & Growth Focused Entry Point Reports - BỘ NỘI VỤ
What market sentiment indicators show for Theriva Biologics Inc. (SFY0) stockEarnings Growth Report & Technical Confirmation Alerts - moha.gov.vn
Theriva Biologics, Inc. (TOVX) 6.8% in After-hours: Despite No Clear Catalyst - Stocks Telegraph
Theriva Biologics (NYSEAMERICAN:TOVX) Trading 3.4% Higher – Still a Buy? - Defense World
Views of Wall Street’s Leading Experts on Theriva Biologics Inc - Setenews
What drives Theriva Biologics Inc stock priceGeopolitical Risk Analysis & Breakthrough Profit Margins - earlytimes.in
TOVX SEC FilingsTHERIVA BIOLOGICS INC 10-K, 10-Q, 8-K Forms - Stock Titan
TOVX 10-Q及美國證券交易委員會申報文件 - Yahoo 財經
How Theriva Biologics Inc. (SFY0) stock reacts to new regulationsJuly 2025 Chart Watch & Risk Controlled Daily Trade Plans - newser.com
How Theriva Biologics Inc. stock responds to policy changes2025 Technical Patterns & Risk Controlled Daily Trade Plans - newser.com
Is Theriva Biologics Inc. (SFY0) stock a top pick for value investors - newser.com
Is Theriva Biologics Inc. (SFY0) stock overpriced at current multiplesJuly 2025 Decliners & Stepwise Swing Trade Plans - newser.com
Can Theriva Biologics Inc. recover in the next quarterJuly 2025 Institutional & Growth Focused Entry Reports - newser.com
How Theriva Biologics Inc. (SFY0) stock responds to bond marketJuly 2025 Analyst Calls & Weekly High Momentum Picks - newser.com
Finanzdaten der Theriva Biologics Inc-Aktie (TOVX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.36%
1.12%
Kapitalisierung:
|
Volumen (24h):